Annual Working Capital
$19.30 M
-$2.81 M-12.72%
December 31, 2023
Summary
- As of February 26, 2025, FENC annual working capital is $19.30 million, with the most recent change of -$2.81 million (-12.72%) on December 31, 2023.
- During the last 3 years, FENC annual working capital has fallen by -$9.77 million (-33.59%).
- FENC annual working capital is now -33.59% below its all-time high of $29.07 million, reached on December 31, 2020.
Performance
FENC Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$50.53 M
-$3.89 M-7.15%
September 30, 2024
Summary
- As of February 26, 2025, FENC quarterly working capital is $50.53 million, with the most recent change of -$3.89 million (-7.15%) on September 30, 2024.
- Over the past year, FENC quarterly working capital has stayed the same.
- FENC quarterly working capital is now -13.38% below its all-time high of $58.34 million, reached on March 31, 2024.
Performance
FENC Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
FENC Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.7% | 0.0% |
| 3 y3 years | -33.6% | 0.0% |
| 5 y5 years | -9.4% | 0.0% |
FENC Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -12.7% | at low | -13.4% | +303.7% |
| 5 y | 5-year | -33.6% | +66.2% | -13.4% | +515.0% |
| alltime | all time | -33.6% | +489.4% | -13.4% | +657.4% |
Fennec Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $50.53 M(-7.2%) |
| Jun 2024 | - | $54.42 M(-6.7%) |
| Mar 2024 | - | $58.34 M(+202.2%) |
| Dec 2023 | $19.30 M(-12.7%) | $19.30 M(+28.4%) |
| Sep 2023 | - | $15.03 M(-3.3%) |
| Jun 2023 | - | $15.55 M(-11.8%) |
| Mar 2023 | - | $17.64 M(-20.2%) |
| Dec 2022 | $22.12 M(+6.7%) | $22.12 M(-18.8%) |
| Sep 2022 | - | $27.23 M(+117.5%) |
| Jun 2022 | - | $12.52 M(-26.3%) |
| Mar 2022 | - | $16.99 M(-18.0%) |
| Dec 2021 | $20.73 M(-28.7%) | $20.73 M(-13.5%) |
| Sep 2021 | - | $23.96 M(-12.0%) |
| Jun 2021 | - | $27.23 M(+9.2%) |
| Mar 2021 | - | $24.93 M(-14.2%) |
| Dec 2020 | $29.07 M(+150.3%) | $29.07 M(-6.8%) |
| Sep 2020 | - | $31.18 M(-12.7%) |
| Jun 2020 | - | $35.71 M(+334.6%) |
| Mar 2020 | - | $8.22 M(-29.3%) |
| Dec 2019 | $11.61 M(-45.5%) | $11.61 M(-21.1%) |
| Sep 2019 | - | $14.72 M(-9.0%) |
| Jun 2019 | - | $16.18 M(-14.4%) |
| Mar 2019 | - | $18.89 M(-11.4%) |
| Dec 2018 | $21.31 M(-20.3%) | $21.31 M(-6.8%) |
| Sep 2018 | - | $22.86 M(-8.0%) |
| Jun 2018 | - | $24.86 M(-3.1%) |
| Mar 2018 | - | $25.66 M(-4.1%) |
| Dec 2017 | $26.76 M(+649.5%) | $26.76 M(+202.1%) |
| Sep 2017 | - | $8.86 M(-8.5%) |
| Jun 2017 | - | $9.68 M(+238.3%) |
| Mar 2017 | - | $2.86 M(-19.9%) |
| Dec 2016 | $3.57 M(+551.5%) | $3.57 M(-15.4%) |
| Sep 2016 | - | $4.22 M(-9.3%) |
| Jun 2016 | - | $4.65 M(+1814.8%) |
| Mar 2016 | - | $243.00 K(-55.7%) |
| Dec 2015 | $548.00 K(-10.6%) | $548.00 K(-46.2%) |
| Sep 2015 | - | $1.02 M(-8.4%) |
| Jun 2015 | - | $1.11 M(+34.6%) |
| Mar 2015 | - | $826.00 K(+34.7%) |
| Dec 2014 | $613.00 K(-142.1%) | $613.00 K(-119.0%) |
| Sep 2014 | - | -$3.23 M(-30.7%) |
| Jun 2014 | - | -$4.66 M(+7.5%) |
| Mar 2014 | - | -$4.33 M(+197.9%) |
| Dec 2013 | -$1.46 M(-70.6%) | -$1.46 M(-64.7%) |
| Sep 2013 | - | -$4.13 M(+69.9%) |
| Jun 2013 | - | -$2.43 M(-73.2%) |
| Mar 2013 | - | -$9.06 M(+82.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | -$4.96 M(+4030.8%) | -$4.96 M(-486.1%) |
| Sep 2012 | - | $1.28 M(-37.2%) |
| Jun 2012 | - | $2.04 M(-21.2%) |
| Mar 2012 | - | $2.60 M(-2262.5%) |
| Dec 2011 | -$120.00 K(-97.6%) | -$120.00 K(-96.7%) |
| Sep 2011 | - | -$3.67 M(+436.5%) |
| Jun 2011 | - | -$684.00 K(+140.0%) |
| Mar 2011 | - | -$285.00 K(-94.2%) |
| Dec 2010 | -$4.92 M(-1292.3%) | -$4.92 M(-178.2%) |
| Sep 2010 | - | $6.30 M(-7.2%) |
| Jun 2010 | - | $6.79 M(>+9900.0%) |
| Mar 2010 | - | $47.00 K(-88.6%) |
| Dec 2009 | $413.00 K(-87.1%) | $413.00 K(-30.0%) |
| Sep 2009 | - | $590.00 K(-38.2%) |
| Jun 2009 | - | $954.00 K(-42.3%) |
| Mar 2009 | - | $1.65 M(-48.5%) |
| Dec 2008 | $3.21 M(-77.3%) | $3.21 M(-39.4%) |
| Sep 2008 | - | $5.30 M(-36.2%) |
| Jun 2008 | - | $8.30 M(-26.2%) |
| Mar 2008 | - | $11.25 M(-20.6%) |
| Dec 2007 | $14.16 M(+1079.9%) | $14.16 M(-15.1%) |
| Sep 2007 | - | $16.68 M(-14.4%) |
| Jun 2007 | - | $19.48 M(-5.8%) |
| Mar 2007 | - | $20.69 M(+1624.1%) |
| Dec 2006 | $1.20 M(-88.8%) | $1.20 M(-79.1%) |
| Sep 2006 | - | $5.74 M(-43.6%) |
| Jun 2006 | - | $10.17 M(+30.7%) |
| Mar 2006 | - | $7.78 M(-27.5%) |
| Dec 2005 | $10.73 M(-46.9%) | $10.73 M(-27.5%) |
| Sep 2005 | - | $14.81 M(+45.6%) |
| Jun 2005 | - | $10.17 M(-24.9%) |
| Mar 2005 | - | $13.54 M(-29.4%) |
| Sep 2004 | - | $19.18 M(-5.1%) |
| Jun 2004 | $20.20 M(+799.8%) | $20.20 M(+44.6%) |
| Mar 2004 | - | $13.97 M(-14.6%) |
| Dec 2003 | - | $16.36 M(+1242.3%) |
| Sep 2003 | - | $1.22 M(-45.7%) |
| Jun 2003 | $2.25 M(-59.1%) | $2.25 M(+104.8%) |
| Mar 2003 | - | $1.10 M(-51.5%) |
| Dec 2002 | - | $2.26 M(-44.0%) |
| Sep 2002 | - | $4.04 M(-26.5%) |
| Jun 2002 | $5.49 M(-41.6%) | $5.49 M(-15.6%) |
| Mar 2002 | - | $6.51 M(-12.7%) |
| Dec 2001 | - | $7.45 M(-8.3%) |
| Sep 2001 | - | $8.13 M(-13.6%) |
| Jun 2001 | $9.41 M(<-9900.0%) | $9.41 M(+79.5%) |
| Dec 2000 | - | $5.24 M |
| Jun 2000 | -$43.60 K | - |
FAQ
- What is Fennec Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Fennec Pharmaceuticals?
- What is Fennec Pharmaceuticals annual working capital year-on-year change?
- What is Fennec Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Fennec Pharmaceuticals?
- What is Fennec Pharmaceuticals quarterly working capital year-on-year change?
What is Fennec Pharmaceuticals annual working capital?
The current annual working capital of FENC is $19.30 M
What is the all time high annual working capital for Fennec Pharmaceuticals?
Fennec Pharmaceuticals all-time high annual working capital is $29.07 M
What is Fennec Pharmaceuticals annual working capital year-on-year change?
Over the past year, FENC annual working capital has changed by -$2.81 M (-12.72%)
What is Fennec Pharmaceuticals quarterly working capital?
The current quarterly working capital of FENC is $50.53 M
What is the all time high quarterly working capital for Fennec Pharmaceuticals?
Fennec Pharmaceuticals all-time high quarterly working capital is $58.34 M
What is Fennec Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, FENC quarterly working capital has changed by $0.00 (0.00%)